Impact Of Chronic Urticaria on Patients’ Quality of Life in Damietta Governorate | ||||
| International Journal of Medical Arts | ||||
| Articles in Press, Accepted Manuscript, Available Online from 04 August 2025 | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/ijma.2025.342463.2171 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Aya Adel Ezzelregal  ; Hany Othman Aboelwafa; Rabie Atallah
| ||||
| Department of Dermatology, Venereology and Andrology, Faculty of Medicine, Al-Azhar University, Damietta, Egypt. | ||||
| Abstract | ||||
| Background: Chronic urticaria is characterized by the presence of recurrent wheal, with or without angioedema, occurring at least twice a week for longer than 6 weeks. Aim: To evaluate the impact of chronic urticaria on patients’ quality of life and to assess its correlation with the severity of the disease in Damietta governorate. Patients and methods: This was a randomized clinical trial included 200 patients with chronic urticarial in dermatology outpatient clinic at Damietta Faculty of Medicine from June 2023 to June 2024 . Results: Over half of patients (54%) experience work and physical activity limitations, while 46% experience sleep and free time limitations. Most patients (70%) have limitations in social relationships, 60% in eating, and 60% in falling asleep. Additionally, 76% wake up at night, 56% are tired during the day, 66% have difficulties concentrating, and 58% often feel nervous. These limitations can impact various aspects of daily life, including sleep, concentration, and overall well-being.There was a statistically significant difference between urticaria activity score and chronic urticaria quality of life questionnaire; as mean of cuQoL was higher among patients with severe urticaria in comparison to patients with mild urticarial. Conclusion: Chronic urticaria significantly impacts patients' quality of life, particularly in those with autoimmune urticaria. The study highlights the importance of evaluating quality of life to assess disease progression and treatment efficacy. The CU-QOL, a reliable and cost-effective tool, is deemed valid for research and clinical practice. | ||||
| Keywords | ||||
| Chronic urticaria; Impact; Patients’ quality of life; Damietta | ||||
|
Statistics Article View: 23 |
||||
